A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection

NCT03174795 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Tract Infections

Interventions

DRUG: RO7079901
DRUG: Meropenem

Sponsor

Hoffmann-La Roche